Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients

Clinical and Experimental Immunology

Volumn 129, Issue 1, 2002, Pages 160-168

  Pang, M ^a,b   Setoyama, Y ^a   Tsuzaka, K ^a   Yoshimoto, K ^a   Amano, K ^a   Abe, T ^a   Takeuchi, T ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Autoimmunity; Signal transduction; TCR zeta chain; Tyrosine phosphorylation

Indexed keywords

PREDNISOLONE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ZETA CHAIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE;

ADULT; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; AUTOIMMUNITY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHORYLATION; PREDNISOLONE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, ANTIGEN, T-CELL; SJOGREN'S SYNDROME; T-LYMPHOCYTE SUBSETS;

EID: 0036379452     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01833.x     Document Type: Article

References (58)

1. Boumpas DT, Austin HAR, Fessler, BJ et al.Systemic lupus erythematosus: emerging concepts. Part 1. Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 1995; 122:940-50.
2. Boumpas DT, Fessler BJ, Austin HAR et al. Systemic lupus erythe-matosus: emerging concepts. Part 2. Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med, 1995; 123:42-53.
3. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994; 330:1871-9.
4. Cohen PL. T- and B-cell abnormalities in systemic lupus. J Invest Dermatol 1993; 100:69s-72s.
5. Tsokos GC. Lymphocyte abnormalities in human lupus. Clin Immunol Immunopathol 1992; 63:7-9.
6. Kotzin BL. Systemic lupus erythematosus. Cell 1996; 85:303-6.
7. Gottlieb AB, Lahita RG, Chiorazzi N, Kunkel HG. Immune function in systemic lupus erythematosus. Impairment of in vitro T cell proliferation and in vivo antibody response to exogenous antigen. J Clin Invest 1979; 63:885-92.
8. Fox DA, Millard JA, Treisman J et al. Defective CD2 pathway T cell activation in systemic lupus erythematosus. Arthritis Rheum 1991; 34:561-71.
9. Huang YP, Miescher PA, Zubler RH. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. J Immunol 1986; 137:3515-20.
10. Linker-Israeli M. Cytokine abnormalities in human lupus. Clin Immunol Immunopathol 1992; 63:10-2.
11. Horwitz DA, Gray JD, Behrendsen SC et al. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 1998; 41:838-44.
12. Stohl W, Elliot JE, Li L et al. Impaired nonrestricted cytolytic activity in systemic lupus erythematosus. Arthritis Rheum 1997; 40:1130-7.
13. Takeuchi T, Tanaka S, Steinberg AD et al. Defective expression of the 2H4 molecule after autologous mixed lymphocyte activation in systemic lupus erythematosus patients. J Clin Invest 1988; 82:1288-94.
14. Sierakowski S, Kucharz EJ, Lightfoot RW, Goodwin JS. Impaired T-cell activation in patients with systemic lupus erythematosus. J Clin Immunol 1989; 9:469-76.
15. Dayal AK, Kammer GM. The T cell enigma in lupus. Arthritis Rheum 1996; 39:23-33.
16. Tada Y, Nagasawa K, Yamauchi Y, Tsukamoto H, Niho Y. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1991; 60:220-31.
17. Kammer GM, Khan I, Malemud C. Defective type I protein kinase Aisozyme activity in systemic lupus erythematosus T lymphocytes. J Clin Invest 1994; 94:422-30.
18. Kammer GM, Khan IU, Kammer JA, Olorenshaw I, Mathis D. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. II. Abnormal isozyme kinetics. J Immunol 1996; 157:2690-8.
19. Takeuchi T, Pang M, Amano K, Koide J, Abe T. Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol 1997; 109:20-6.
20. Ullman KS, Northrop JP, Verweij CL, Crabtree GR. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Ann Rev Immunol 1990; 8:421-52.
21. Weiss A, Littman DR. Signal transduction by lymphocyte antigen receptors. Cell 1994; 76:263-74.
22. Weiss A. T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell 1993; 73:209-12.
23. Samelson LE, Klausner RD. Tyrosine kinases and tyrosine-based activation motifs. Current research on activation via the T cell antigen receptor. J Biol Chem 1992; 267:24913-6.
24. Amano K, Takeuchi T, Abe T. Imbalanced tyrosine phosphorylation in signal transduction molecules in SLE T cells. Arthritis Rheum 1996; 39:S118.
25. Takeuchi T, Tsuzaka K, Pang M, Amano K, Koide J, Abe T. TCR zeta chain lacking exon 7 in two patients with systemic lupus erythematosus. Int Immunol 1998; 10:911-21.
26. Liossis SN, Ding XZ, Dennis GJ, Tsokos GC. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest 1998; 101:1448-57.
27. Weissman AM, Baniyash M, Hou D, Samelson LE, Burgess WH, Klausner RD. Molecular cloning of thez chain of the T cell antigen receptor. Science 1988; 239:1018-20.
28. Frank SJ, Niklinska BB, Orloff DG, Mercep M, Ashwell JD, Klausner RD. Structural mutations of the T cell receptor zeta chain and its role in T cell activation. Science 1990; 249:174-7.
29. Irving BA, Weiss A. The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 1991; 64:891-901.
30. Geisler C, Kuhlmann J, Rubin B. Assembly, intracellular processing, and expression at the cell surface of the human alpha beta T cell receptor/CD3 complex. Function of the CD3-zeta chain. J Immunol 1989; 143:4069-77.
31. Tan EM, Cohen AS, Fries JF, Masi AT, MaShane DJ. Rothfield criteria for the classification of system lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
32. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35:630-40.
33. Takeuchi T, Amano K, Sekine H, Koide J, Abe T. Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis. J Clin Invest 1993; 92:3008-16.
34. Pang M, Abe T, Fujihara T et al. aEβ7, a novel integrin adhesion molecule is upregulated on T cells from SLE patients with specific epithelial involvement. Arthritis Rheum 1998; 41:1456-63.
35. Anderson P, Blue ML, O'Brien C, Schlossman SF. Monoclonal antibodies reactive with the T cell receptor zeta chain. production and characterization using a new method. J Immunol 1899; 143:1899-904.
36. Koyasu S, McConkey DJ, Clayton LK et al. Phosphorylation of multiple CD3 zeta tyrosine residues leads to formation of pp21 in vitro and in vivo. Structural changes upon T cell receptor stimulation. J Biol Chem 1992; 267:3375-81.
37. Wegener AM, Letourneur F, Hoeveler A, Brocker T, Luton F, Malissen B. The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell 1992; 68:83-95.
38. Koning F, Maloy WL, Coligan JE. The implications of subunit interactions for the structure of the T cell receptor-CD3 complex. Eur J Immunol 1990; 20:299-305.
39. Blumberg RS, Ley S, Sancho J et al. Structure of the T-cell antigen receptor: evidence for two CD3 epsilon subunits in the T-cell receptor-CD3 complex. Proc Natl Acad Sci USA 1990; 87:7220-4.
40. De la Hera A, Muller U, Olsson C, Isaaz S, Tunnacliffe A. Structure of the T cell antigen receptor (TCR): two CD3 epsilon subunits in a functional TCR/CD3 complex. J Exp Med 1991; 173:7-17.
41. Yamazaki T, Arase H, Ono S, Ohno H, Watanabe H, Saito T. A shift from negative to positive selection of autoreactive T cells by the reduced level of TCR signal in TCR-transgenic CD3 zeta-deficient mice. J Immunol 1997; 158:1634-40.
42. Sussman JJ, Bonifacino JS, Lippincott-Schwartz J et al.Failure to synthesize the T cell CD3-zeta chain. structure and function of a partial T cell receptor complex. Cell 1988; 52:85-95.
43. Love PE, Shores EW, Johnson MD et al. T cell development in mice that lack the zeta chain of the T cell antigen receptor complex. Science 1993; 261:918-21.
44. Yang M, Omura S, Bonifacino JS, Weissman AM. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells: importnace of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes. J Exp Med 1998; 187:835-46.
45. Gringhuis SI, Leow A, Papendrecht-van der Voort EAM, Remans PHJ, Breedveld FC, Verweij CL. Displacement of linkers for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis. J Immunol 2000; 164:2170-9.
46. Tartour E, Latour S, Mathiot C et al. Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: relationship with TIL phenotype and function. Int J Cancer 1995; 63:205-12.
47. Salvadori S, Gansbacher B, Pizzimenti AM, Zier KS. Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors. J Immunol 1994; 153:5176-82.
48. Maurice MM, Lankester AC, Bezemer AC et al. Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J Immunol 1997; 159:2973-8.
49. Maurice MM, Nakamura H, van der Voort EA et al. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol 1997; 158:1458-65.
50. Aoe T, Okamoto Y, Saito T. Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J Exp Med 1995; 181:1881-6.
51. Isomaki P, Panesar M, Annenkov A et al. Prolonged exposure of T cells to TNF down-regulates TCRζ and expression of the TCR/CD3 complex at the cell surface. J Immunol 2001; 166:5495-507.
52. Tsuzaka K, Takeuchi T, Onoda N, Abe T. Mutations in T cell receptor zeta chain mRNA of peripheral T cells from systemic lupus erythematosus patients. J Autoimmunol 1997; 11:381-5.
53. Poussier P, Edouard P, Lee C, Binnie M, Julius M. Thymus-independent development and negative selection of T cells expressing T cell receptor alpha/beta in the intestinal epithelium: evidence for distinct circulation patterns of gut- and thymus-derived T lymphocytes. J Exp Med 1992; 176:187-99.
54. + lymphocytes reveals a major extrathymic pathway of T cell differentiation. J Exp Med 1991; 173:483-6.
55. Shores EW, Tran T, Grinberg A, Sommers CL, Shen H, Love PE. Role of the multiple T cell receptor (TCR)-zeta chain signaling motifs in selection of the T cell repertoire. J Exp Med 1997; 185:893-900.
56. Lin S-Y, Ardouin L, Gillet A, Malissen M, Malissen B. The single positive T cells found in CD3-ζ/η-/- mice overtly react with self-major histocompatibility complex molecules upon restoration of normal surface density of T cell receptor-CD3 complex. J Exp Med 1997; 185:707-15.
57. Shores EW, Ono M, Kawabe T et al.T cell development in mice lacking all T cell receptor zeta family members (zeta, eta, and Fcepsilon-RIgamma). J Exp Med 1998; 187:1093-101.
58. Saloijin KV, Zhang J, Madrenas J, Delovitch TL. T-cell anergy and altered T-cell receptor signaling: effects on autoimmune disease. Immunol Today 1998; 19:468-73.